Heme controls the regulation of protein tyrosine kinases Jak2 and Src

Biochemical and Biophysical Research Communications

Volumn 403, Issue 1, 2010, Pages 30-35

  Yao, Xiao ^a   Balamurugan, Parimaladevi ^a   Arvey, Aaron ^b   Leslie, Christina ^b   Zhang, Li ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Heme; Heme regulation; Jak2; Phosphorylation; Src; Tyrosine kinase

Indexed keywords

HEME; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE KINASE;

ARTICLE; CONFORMATIONAL TRANSITION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME CONFORMATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HEME; HUMANS; JANUS KINASE 2; RNA INTERFERENCE; SRC-FAMILY KINASES;

MAMMALIA;

EID: 78649704465     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.101     Document Type: Article

References (45)

1. Schlessinger J., Lemmon M.A. SH2 and PTB domains in tyrosine kinase signaling. Sci. STKE 2003, RE12.
2. Perona R. Cell signalling: growth factors and tyrosine kinase receptors. Clin. Transl. Oncol. 2006, 8:77-82.
3. Csiszar A. Structural and functional diversity of adaptor proteins involved in tyrosine kinase signalling. Bioessays 2006, 28:465-479.
4. Filippakopoulos P., Muller S., Knapp S. SH2 domains: modulators of nonreceptor tyrosine kinase activity. Curr. Opin. Struct. Biol. 2009, 19:643-649.
5. Tohyama Y., Yamamura H. Protein tyrosine kinase, syk: a key player in phagocytic cells. J. Biochem. 2009, 145:267-273.
6. Gilfillan A.M., Rivera J. The tyrosine kinase network regulating mast cell activation. Immunol. Rev. 2009, 228:149-169.
7. Mocsai A., Ruland J., Tybulewicz V.L. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat. Rev. Immunol. 2010, 10:387-402.
8. Yim E.K., Siwko S., Lin S.Y. Exploring Rak tyrosine kinase function in breast cancer. Cell Cycle 2009, 8:2360-2364.
9. Stirewalt D.L., Meshinchi S. Receptor tyrosine kinase alterations in AML - biology and therapy. Cancer Treat Res. 2009, 145:85-108.
10. Wagh P.K., Peace B.E., Waltz S.E. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. Adv. Cancer Res. 2008, 100:1-33.
11. Sequist L.V., Lynch T.J. EGFR tyrosine kinase inhibitors in lung cancer: an evolving story. Annu. Rev. Med. 2008, 59:429-442.
12. Lin J., Arlinghaus R. Activated c-Abl tyrosine kinase in malignant solid tumors. Oncogene 2008, 27:4385-4391.
13. Guarino M. Src signaling in cancer invasion. J. Cell Physiol. 2010, 223:14-26.
14. Fizazi K. The role of Src in prostate cancer. Ann. Oncol. 2007, 18:1765-1773.
15. Li S. Src kinase signaling in leukaemia. Int. J. Biochem. Cell Biol. 2007, 39:1483-1488.
16. Verma A., Kambhampati S., Parmar S., Platanias L.C. Jak family of kinases in cancer. Cancer Metastasis Rev. 2003, 22:423-434.
17. Constantinescu S.N., Girardot M., Pecquet C. Mining for JAK-STAT mutations in cancer. Trends Biochem. Sci. 2008, 33:122-131.
18. Valentino L., Pierre J. JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem. Pharmacol. 2006, 71:713-721.
19. Ortiz de Montellano P.R. Hemes in Biology, Wiley Encyclopedia of Chemical Biology 2009, John Wiley & Sons, Ltd, West Sussex, pp. 240-249.
20. Mense S.M., Zhang L. Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases. Cell Res. 2006, 16:681-692.
21. Hou S., Reynolds M.F., Horrigan F.T., Heinemann S.H., Hoshi T. Reversible binding of heme to proteins in cellular signal transduction. Acc. Chem. Res. 2006, 39:918-924.
22. Yin L., Wu N., Curtin J.C., Qatanani M., Szwergold N.R., Reid R.A., Waitt G.M., Parks D.J., Pearce K.H., Wisely G.B., Lazar M.A. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 2007, 318:1786-1789.
23. Zhang L., Guarente L. Heme binds to a short sequence that serves a regulatory function in diverse proteins. EMBO J. 1995, 14:313-320.
24. Hira S., Tomita T., Matsui T., Igarashi K., Ikeda-Saito M. Bach1, a heme-dependent transcription factor, reveals presence of multiple heme binding sites with distinct coordination structure. IUBMB Life 2007, 59:542-551.
25. Liu S., Bhattacharya S., Han A., Suragani R.N., Zhao W., Fry R.C., Chen J.J. Haem-regulated eIF2alpha kinase is necessary for adaptive gene expression in erythroid precursors under the stress of iron deficiency. Br. J. Haematol. 2008, 143:129-137.
26. Yun B.G., Matts J.A., Matts R.L. Interdomain interactions regulate the activation of the heme-regulated eIF 2 alpha kinase. Biochim. Biophys. Acta 2005, 1725:174-181.
27. Igarashi J., Murase M., Iizuka A., Pichierri F., Martinkova M., Shimizu T. Elucidation of the heme binding site of heme-regulated eukaryotic initiation factor 2alpha kinase and the role of the regulatory motif in heme sensing by spectroscopic and catalytic studies of mutant proteins. J. Biol. Chem. 2008, 283:18782-18791.
28. Faller M., Matsunaga M., Yin S., Loo J.A., Guo F. Heme is involved in microRNA processing. Nat. Struct. Mol. Biol. 2007, 14:23-29.
29. Ye W., Zhang L. Heme controls the expression of cell cycle regulators and cell growth in HeLa cells. Biochem. Biophys. Res. Commun. 2004, 315:546-554.
30. Zhu Y., Hon T., Ye W., Zhang L. Heme deficiency interferes with the Ras-mitogen-activated protein kinase signaling pathway and expression of a subset of neuronal genes. Cell Growth Differ. 2002, 13:431-439.
31. Hach A., Hon T., Zhang L. A new class of repression modules is critical for heme regulation of the yeast transcriptional activator Hap1. Mol. Cell. Biol. 1999, 19:4324-4333.
32. Hon T., Hach A., Lee H.C., Cheng T., Zhang L. Functional analysis of heme regulatory elements of the transcriptional activator Hap1. Biochem. Biophys. Res. Commun. 2000, 273:584-591.
33. Sengupta A., Hon T., Zhang L. Heme deficiency suppresses the expression of key neuronal genes and causes neuronal cell death. Brain Res. Mol. Brain Res. 2005, 137:23-30.
34. Yang J., Kim K.D., Lucas A., Drahos K.E., Santos C.S., Mury S.P., Capelluto D.G., Finkielstein C.V. A novel heme-regulatory motif mediates heme-dependent degradation of the circadian factor period 2. Mol. Cell. Biol. 2008, 28:4697-4711.
35. Zhu Y., Hon T., Zhang L. Heme initiates changes in the expression of a wide array of genes during the early erythroid differentiation stage. Biochem. Biophys. Res. Commun. 1999, 258:87-93.
36. Zhu Y., Lee H.C., Zhang L. An examination of heme action in gene expression: heme and heme deficiency affect the expression of diverse genes in erythroid k562 and neuronal PC12 cells. DNA Cell Biol. 2002, 21:333-346.
37. Ye W., Zhang L. Heme deficiency causes apoptosis but does not increase ROS generation in HeLa cells. Biochem. Biophys. Res. Commun. 2004, 319:1065-1071.
38. Bradshaw J.M. The Src, Syk, and Tec family kinases: distinct types of molecular switches. Cell Signal. 2010, 22:1175-1184.
39. Feng J., Witthuhn B.A., Matsuda T., Kohlhuber F., Kerr I.M., Ihle J.N. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 1997, 17:2497-2501.
40. Kurdi M., Booz G.W. JAK redux: a second look at the regulation and role of JAKs in the heart. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1545-H1556.
41. Tsiftsoglou A.S., Tsamadou A.I., Papadopoulou L.C. Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol Ther. 2006, 111:327-345.
42. Zhang L., Hach A. Molecular mechanism of heme signaling in yeast: the transcriptional activator Hap1 serves as the key mediator. Cell. Mol. Life Sci. 1999, 56:415-426.
43. Ogawa K., Sun J., Taketani S., Nakajima O., Nishitani C., Sassa S., Hayashi N., Yamamoto M., Shibahara S., Fujita H., Igarashi K. Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO J. 2001, 20:2835-2843.
44. Kitanishi K., Igarashi J., Hayasaka K., Hikage N., Saiful I., Yamauchi S., Uchida T., Ishimori K., Shimizu T. Heme-binding characteristics of the isolated PAS-A domain of mouse Per2, a transcriptional regulatory factor associated with circadian rhythms. Biochemistry 2008, 47:6157-6168.
45. Raghuram S., Stayrook K.R., Huang P., Rogers P.M., Nosie A.K., McClure D.B., Burris L.L., Khorasanizadeh S., Burris T.P., Rastinejad F. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat. Struct. Mol. Biol. 2007, 14:1207-1213.